Matches in Wikidata for { <http://www.wikidata.org/entity/Q65356365> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q65356365 description "clinical trial" @default.
- Q65356365 description "ensayu clínicu" @default.
- Q65356365 description "klinisch onderzoek" @default.
- Q65356365 description "клінічне випробування" @default.
- Q65356365 description "կլինիկական փորձարկում" @default.
- Q65356365 name "A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate" @default.
- Q65356365 name "A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate" @default.
- Q65356365 type Item @default.
- Q65356365 label "A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate" @default.
- Q65356365 label "A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate" @default.
- Q65356365 prefLabel "A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate" @default.
- Q65356365 prefLabel "A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate" @default.
- Q65356365 P1050 Q65356365-E96B75E1-BE3F-4236-A9AA-1A9A12562B5B @default.
- Q65356365 P1132 Q65356365-50AF8DED-4EF8-481F-A77E-8510C96E308C @default.
- Q65356365 P1476 Q65356365-6E15DF73-B00A-4F67-9F48-7D113573CF14 @default.
- Q65356365 P17 Q65356365-1F4984A9-2A42-4343-B43C-81960E60D5BF @default.
- Q65356365 P2899 Q65356365-E2A53C59-A612-42A4-B411-B94F555730B9 @default.
- Q65356365 P3098 Q65356365-C1A0D653-7062-4793-A7B6-1949E7BA4264 @default.
- Q65356365 P31 Q65356365-46663A62-BDB2-4C28-9EDD-F2DB5CC1506B @default.
- Q65356365 P580 Q65356365-DC3FEAB1-6EE7-45D5-84D3-A27C1B86CB9C @default.
- Q65356365 P582 Q65356365-28ECBC0B-0B5A-4788-BB4C-5E36D33492D3 @default.
- Q65356365 P6099 Q65356365-33D3969D-9FCB-4613-A473-885194C231EE @default.
- Q65356365 P6153 Q65356365-3807C7B9-3BC6-4766-B056-391C5AFB3078 @default.
- Q65356365 P6153 Q65356365-4A65DC08-A22C-4EA7-8D2D-833DB81E6C3C @default.
- Q65356365 P6153 Q65356365-4AD8C8BD-4469-4CAB-8DCC-95E47AFCE35E @default.
- Q65356365 P6153 Q65356365-D4629DB2-2E5B-4EA0-B475-B009BB2FE847 @default.
- Q65356365 P8363 Q65356365-D52D94D8-6C38-4972-8D21-5394348DB006 @default.
- Q65356365 P1050 Q170990 @default.
- Q65356365 P1132 "+112" @default.
- Q65356365 P1476 "A Randomized, Double-blind, Placebo-controlled, Phase 2 Study To Assess The Immune Response Following Administration Of Zoster Vaccine To Subjects With Rheumatoid Arthritis Receiving Tofacitinib (Cp-690,550) Or Placebo With Background Methotrexate Treatment" @default.
- Q65356365 P17 Q30 @default.
- Q65356365 P2899 "+50" @default.
- Q65356365 P3098 "NCT02147587" @default.
- Q65356365 P31 Q30612 @default.
- Q65356365 P580 "2014-06-01T00:00:00Z" @default.
- Q65356365 P582 "2015-06-01T00:00:00Z" @default.
- Q65356365 P6099 Q42824440 @default.
- Q65356365 P6153 Q174710 @default.
- Q65356365 P6153 Q30269584 @default.
- Q65356365 P6153 Q30270272 @default.
- Q65356365 P6153 Q5225736 @default.
- Q65356365 P8363 Q78089383 @default.